BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7172892)

  • 1. [Alterations of blood dopamine-beta-hydroxylase activity in patients with intrahepatic portal hypertension].
    Du RY
    Zhonghua Wai Ke Za Zhi; 1982 Jul; 20(7):394-6. PubMed ID: 7172892
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of blood dopamine-beta-hydroxylase activity in patients with intrahepatic portal hypertension.
    Du RY; Wang XH; Huang CT; Chen J
    Chin Med J (Engl); 1982 Oct; 95(10):737-40. PubMed ID: 6817977
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum dopamine-beta-hydroxylase: a possible aid in the evaluation of hypertension.
    Schanberg SM; Stone RA; Kirshner N; Gunnells JC; Robinson RR
    Adv Biochem Psychopharmacol; 1974; 12(0):129-33. PubMed ID: 4608516
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasma dopamine beta-hydroxylase activity in hypertension treated with adrenergic beta receptor blockaders].
    Merkulova NK
    Ter Arkh; 1981; 53(1):69-72. PubMed ID: 7221913
    [No Abstract]   [Full Text] [Related]  

  • 5. [Degree of dopamine beta-hydroxylase activity of blood plasma in hypertension].
    Merkulova NK; Temirov AA
    Ter Arkh; 1978; 50(12):46-50. PubMed ID: 741373
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in plasma dopamine beta-hydroxylase activity in patients with hypertension treated with clofelin].
    Merkulova NK
    Ter Arkh; 1983; 55(5):77-80. PubMed ID: 6137076
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Serum dopamine-beta-hydroxylase: a possible aid in the evaluation of hypertension.
    Schanberg SM; Stone RA; Kirshner N
    Psychopharmacol Bull; 1974 Jul; 10(3):27-8. PubMed ID: 4419441
    [No Abstract]   [Full Text] [Related]  

  • 8. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M
    J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and structural basis of portal hypertension.
    Moreau R; Lebrec D
    Clin Liver Dis; 2006 Aug; 10(3):445-57, vii. PubMed ID: 17162222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Craviten on blood dopamine beta-hydroxylase activity].
    Grabowska M; Gumińska M; Eckstein M
    Folia Med Cracov; 1980; 22(3-4):359-66. PubMed ID: 7286841
    [No Abstract]   [Full Text] [Related]  

  • 11. [The dopamine theory of schizophrenia: reduced serum dopamine beta hydroxylase activity in paranoid schizophrenia].
    Lipcsey A
    Orv Hetil; 1981 Feb; 122(8):483. PubMed ID: 7290692
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activity of plasma dopamine-beta-hydroxylase in newborn infants. Implication in prematurity, maternal pathology and growth].
    Sizun J; Caroff J; Girin E; Barthelemy L; Alix D
    Pathol Biol (Paris); 1993 Sep; 41(7):610-2. PubMed ID: 8255613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Schistosomal portal hypertension: influence of the portal blood flow in serum levels of hepatic enzymes].
    Alves A; Fontes DA; de Melo VA; Machado MC; Cruz JF; Santos EA
    Arq Gastroenterol; 2003; 40(4):203-8. PubMed ID: 15264040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats.
    Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L
    Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma dopamine beta-hydroxylase activity in clinically healthy children].
    Mello P; Stagni S; Gualandi S; Illuminati B; Guidi M; Corsini F
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1597-602. PubMed ID: 7459080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum dopamine-beta-hydroxylase activity in female manic-depressive patients.
    Rihmer Z; Bagdy G; Arató M
    Biol Psychiatry; 1984 Mar; 19(3):423-7. PubMed ID: 6722232
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of midday serum dopamine-beta-hydroxylase activity in depressed patients and normal controls.
    Nasr S; Daiguji M; Tong C; Meltzer HY
    Commun Psychopharmacol; 1980; 4(4):263-7. PubMed ID: 7273701
    [No Abstract]   [Full Text] [Related]  

  • 19. [A study of plasma dopamine-beta-hydroxylase activity in patients with schizophrenia].
    Kuang PG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):193-7. PubMed ID: 7183426
    [No Abstract]   [Full Text] [Related]  

  • 20. Alcohol susceptibility and plasma dopamine beta-hydroxylase activity.
    Ewing JA; Rouse BA; Mueller RA
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):551-4. PubMed ID: 4850475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.